← Back to patent-cliff list
Mosapride Citrate
Tier C — Watch / tradeMosapride Citrate
-
Originator
1998
First approval
-
Expiry (public)
$0.27B ▲
Peak sales
Small molecule
Type
Targets：5-HT4
Brand：Gasmotin
Indications (approved)：Gastritis
Regional status
US
-
EU
-
China
Approved
1999-11-29
Japan
Approved
1998-06-30
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Mosapride Citrate?
Approved indications include: Gastritis.
When does the Mosapride Citrate patent expire?
No public expiry year is available for Mosapride Citrate yet; this page updates once verified.
How do I get a quote for Mosapride Citrate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27